Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.

Pinto, Navin; Cipkala, Douglas A; Ladd, Patricia E; Pu, Yonglin; Cohn, Susan L

Pinto, Navin; Cipkala, Douglas A; Ladd, Patricia E; Pu, Yonglin; Cohn, Susan L.

Affiliation

Pinto N; Department of Pediatrics, Section of Pediatric Hematology/Oncology, The University of Chicago, Chicago, Illinois.

Pediatr Blood Cancer ; 61(6): 1104-6, 2014 Jun.

Article in En | MEDLINE | ID: mdl-24293072

Subject(s)

Antineoplastic Agents/therapeutic use; Isotretinoin/therapeutic use; Neuroblastoma/secondary; Abdominal Neoplasms/drug therapy; Abdominal Neoplasms/genetics; Abdominal Neoplasms/secondary; Abdominal Neoplasms/surgery; Adrenal Gland Neoplasms/genetics; Adrenal Gland Neoplasms/surgery; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Biomarkers, Tumor; Combined Modality Therapy; Disease Progression; Female; Humans; Infant; Lymphatic Metastasis; Male; Neuroblastoma/drug therapy; Neuroblastoma/genetics; Neuroblastoma/surgery; Orbital Neoplasms/drug therapy; Orbital Neoplasms/genetics; Orbital Neoplasms/secondary; Prognosis; Retroperitoneal Neoplasms/drug therapy; Retroperitoneal Neoplasms/genetics; Retroperitoneal Neoplasms/surgery; Risk; Salvage Therapy; Thoracic Neoplasms/drug therapy; Thoracic Neoplasms/genetics; Thoracic Neoplasms/secondary; Treatment Outcome; Watchful Waiting

Key words

intermediate-risk neuroblastoma; neuroblastoma; refractory disease

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Isotretinoin / Neuroblastoma / Antineoplastic Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google